迈威生物-U
(688062)
| 流通市值：71.26亿 | | | 总市值：139.46亿 |
| 流通股本：2.04亿 | | | 总股本：4.00亿 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 |
| 每股收益(元) | -0.51 | -2.64 | -1.68 | -1.03 | -0.60 | -2.44 | -1.73 | -1.06 |
| 每股净资产(元) | 6.02 | 6.47 | 7.31 | 7.91 | 8.27 | 8.80 | 9.38 | 9.97 |
| 每股资本公积金(元) | 14.91 | 14.84 | 14.73 | 14.68 | 14.63 | 14.55 | 14.47 | 14.39 |
| 每股未分配利润(元) | -9.90 | -9.39 | -8.44 | -7.79 | -7.35 | -6.75 | -6.09 | -5.42 |
| 每股经营性现金流(元) | -0.83 | -1.96 | -1.41 | -0.80 | -0.38 | -1.80 | -1.27 | -0.66 |
| 净资产收益率(%) | -8.24 | -34.54 | -20.92 | -12.39 | -7.07 | -26.24 | -17.17 | -10.20 |
| 营业总收入(元) | 6755.51万 | 1.28亿 | 9951.14万 | 8996.14万 | 403.94万 | 2772.82万 | 2042.41万 | 1105.43万 |
营业总收入同比增长(%) | 1572.42 | 361.03 | 387.22 | 713.81 | -0.70 | 70.88 | 90.73 | 62.99 | | 归属净利润(元) | -20565.85万 | -105343.27万 | -67328.65万 | -41352.51万 | -24110.54万 | -95523.46万 | -69242.19万 | -42328.13万 |
| 归属净利润同比增长(%) | 14.70 | -10.28 | 2.76 | 2.30 | -9.42 | -24.12 | -34.54 | -24.72 |
| 扣非净利润(元) | -21785.67万 | -105992.61万 | -67769.15万 | -41553.50万 | -24242.45万 | -96682.48万 | -70029.26万 | -42826.65万 |
|
| 扣非净利润同比增长(%) | 10.13 | -9.63 | 3.23 | 2.97 | -9.84 | -25.23 | -40.49 | -35.29 |
| 毛利率(%) | 98.69 | 98.93 | 99.59 | 99.80 | 99.46 | 99.75 | 99.67 | 99.44 |
| 净利率(%) | -305.25 | -828.26 | -679.94 | -462.36 | -5983.75 | -3455.42 | -3390.32 | -3852.96 |
| 资产负债率(%) | 48.39 | 42.24 | 34.52 | 32.19 | 29.08 | 24.00 | 19.82 | 16.22 |
| 存货周转率(次) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |